QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-third of one redeemable warrant |
The | |||
The | ||||
The |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
Page No. |
||||||
Item 1. |
1 |
|||||
1 |
||||||
2 |
||||||
3 |
||||||
4 |
||||||
5 |
||||||
Item 2. |
22 |
|||||
Item 3. |
25 |
|||||
Item 4. |
25 |
|||||
Item 1. |
26 |
|||||
Item 1A. |
26 |
|||||
Item 2. |
27 |
|||||
Item 3. |
27 |
|||||
Item 4. |
27 |
|||||
Item 5. |
27 |
|||||
Item 6. |
27 |
|||||
28 |
September 30, 2021 |
December 31, 2020 |
|||||||
(Unaudited) |
||||||||
Assets |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Prepaid expenses |
||||||||
Total current assets |
||||||||
Investments held in Trust Account |
||||||||
Total Assets |
$ |
$ |
||||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
||||||||
Current liabilities |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued expenses |
||||||||
Due to related party |
||||||||
Total current liabilities |
||||||||
Derivative warrant liabilities |
||||||||
Deferred underwriting commissions |
||||||||
Total Liabilities |
||||||||
Commitments and Contingencies |
||||||||
Class A ordinary shares; |
||||||||
Shareholders’ Deficit: |
||||||||
Preference shares, $ and December 31, 2020 |
||||||||
Class A ordinary shares, $ September 30, 2021 and December 31, 2020 |
||||||||
Class B ordinary shares, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total Shareholders’ Deficit |
( |
) | ( |
) | ||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
$ |
$ |
||||||
For the Three Months Ended September 30, 2021 |
For the Nine Months Ended September 30, 2021 |
For the Period From August 28, 2020 (inception) through September 30, 2020 |
||||||||||
General and administrative expenses |
$ | $ | $ | |||||||||
Administrative fee - related party |
||||||||||||
|
|
|
|
|
|
|||||||
Loss from operations |
( |
) | ( |
) | ( |
) | ||||||
Change in fair value of derivative warrant liabilities |
||||||||||||
Net income earned on investments held in Trust Account |
||||||||||||
|
|
|
|
|
|
|||||||
Net income (loss) |
$ | $ | $ | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Weighted average shares outstanding of Class A ordinary shares, basic and diluted |
||||||||||||
|
|
|
|
|
|
|||||||
Basic and diluted net income per share, Class A ordinary shares |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Weighted average shares outstanding of Class B ordinary shares, basic and diluted |
||||||||||||
|
|
|
|
|
|
|||||||
Basic and diluted net income (loss) per share, Class B, ordinary shares |
$ | $ | $ | ( |
) | |||||||
|
|
|
|
|
|
For the Three and Nine Months Ended September 30, 2021 |
||||||||||||||||||||||||||||
Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance - December 31, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance - March 31, 2021 (unaudited), as restated (See Note 2) |
( |
) |
( |
) | ||||||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance - June 30, 2021 (unaudited), as restated (See Note 2) |
( |
) |
( |
) | ||||||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - September 30, 2021 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Period from August 28, 2020 (inception) through September 30, 2020 |
||||||||||||||||||||||||||||
Ordinary Shares |
Additional Paid-In Capital |
Accumulated Deficit |
Total Shareholders ’ Deficit |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance - August 28, 2020 (inception) |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||
Issuance of Class B ordinary share to Sponsor |
— | — | — | |||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - September 30, 2020 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2021 |
For the Period from August 28, 2020 (inception) through September 30, 2020 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Adjustments to reconcile net income (loss) to net cash and cash equivalents used in operating activities: |
|
|||||||
General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares |
— | |||||||
General and administrative expenses paid by Sponsor under note payable |
— | |||||||
Net income earned on investments held in Trust Account |
( |
) | — | |||||
Change in fair value of derivative warrant liabilities |
( |
) | — | |||||
Changes in operating assets and liabilities: |
— | |||||||
Prepaid expenses |
||||||||
Accounts payable |
— | |||||||
Accrued expenses |
||||||||
Due to related party |
— | |||||||
|
|
|
|
|||||
Net cash and cash equivalents used in operating activities |
( |
) | — | |||||
|
|
|
|
|||||
Net decrease in cash and cash equivalents |
( |
) | — | |||||
Cash and cash equivalents - beginning of the period |
— | |||||||
|
|
|
|
|||||
Cash and cash equivalents - end of the period |
$ |
$ |
— |
|||||
|
|
|
|
|||||
Supplemental disclosure of noncash financing activities: |
||||||||
Offering costs included in accounts payable |
$ | — | $ | |||||
Offering costs included in accrued expenses |
$ | — | $ | |||||
Offering costs included in note payable |
$ | — | $ |
As of March 31, 2021 |
As Reported |
Adjustment |
As Restated |
|||||||||
Total assets |
$ |
$ |
$ |
|||||||||
Total liabilities |
$ |
$ |
$ |
|||||||||
Class A ordinary shares subject to possible redemption |
||||||||||||
Preference shares |
||||||||||||
Class A ordinary shares |
( |
) |
||||||||||
Class B ordinary shares |
||||||||||||
Additional paid-in capital |
( |
) |
||||||||||
Accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total shareholders’ equity (deficit) |
$ |
$ |
( |
) |
( |
) | ||||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) |
$ |
$ |
$ |
Three Months Ended March 31, 2021 |
||||||||||||
As Reported |
Adjustment |
As Restated |
||||||||||
Supplemental Disclosure of Noncash Financing Activities: |
||||||||||||
Change in value of Class A ordinary shares subject to possible redemption |
$ |
( |
) |
$ |
$ |
As of June 30, 2021 |
As Reported |
Adjustment |
As Restated |
|||||||||
Total assets |
$ |
$ |
$ |
|||||||||
Total liabilities |
$ |
$ |
$ |
|||||||||
Class A ordinary shares subject to possible redemption |
||||||||||||
Preference shares |
||||||||||||
Class A ordinary shares |
( |
) |
||||||||||
Class B ordinary shares |
||||||||||||
Additional paid-in capital |
( |
) |
||||||||||
Accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
|
|
|
|
|
|
|||||||
Total shareholders’ equity (deficit) |
$ |
$ |
( |
) |
$ |
( |
) | |||||
|
|
|
|
|
|
|||||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) |
$ |
$ |
$ |
|||||||||
|
|
|
|
|
|
Six Months Ended June 30, 2021 |
||||||||||||
As Reported |
Adjustment |
As Restated |
||||||||||
Supplemental Disclosure of Noncash Financing Activities: |
||||||||||||
Change in value of Class A ordinary shares subject to possible redemption |
$ |
$ |
( |
) |
$ |
Earnings Per Share |
||||||||||||
As Reported |
Adjustment |
As Restated |
||||||||||
Three Months Ended March 31, 2021 |
||||||||||||
Net income |
$ |
$ |
$ |
|||||||||
Weighted average shares outstanding - Class A ordinary shares |
||||||||||||
Basic and diluted earnings per share - Class A ordinary shares |
$ |
$ |
$ |
|||||||||
Weighted average shares outstanding - Class B ordinary shares |
||||||||||||
Basic and diluted earnings per share - Class B ordinary shares |
$ |
$ |
( |
) |
$ |
Earnings Per Share |
||||||||||||
As Reported |
Adjustment |
As Restated |
||||||||||
Three Months Ended June 30, 2021 |
||||||||||||
Net income |
$ |
$ |
$ |
|||||||||
Weighted average shares outstanding - Class A ordinary shares |
||||||||||||
Basic and diluted earnings per share - Class A ordinary shares |
$ |
$ |
$ |
|||||||||
Weighted average shares outstanding - Class B ordinary shares |
||||||||||||
Basic and diluted earnings per share - Class B ordinary shares |
$ |
$ |
$ |
Earnings Per Share |
||||||||||||
As Reported |
Adjustment |
As Restated |
||||||||||
Six Months Ended June 30, 2021 |
||||||||||||
Net income |
$ |
$ |
$ |
|||||||||
Weighted average shares outstanding - Class A ordinary shares |
||||||||||||
Basic and diluted earnings per share - Class A ordinary shares |
$ |
$ |
$ |
|||||||||
Weighted average shares outstanding - Class B ordinary shares |
||||||||||||
Basic and diluted earnings per share - Class B ordinary shares |
$ |
$ |
( |
) |
$ |
• |
Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; |
• |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
For the Three Months Ended September 30, 2021 |
For the Nine Months Ended September 30, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net income per ordinary share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average ordinary shares outstanding |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per ordinary share |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
For the Period From August 28, 2020 (inception) through September 30, 2020 |
||||||||
Class A |
Class B |
|||||||
Basic and diluted net loss per ordinary share: |
||||||||
Numerator: |
||||||||
Allocation of net loss |
$ | |
$ | ( |
) | |||
Denominator: |
||||||||
Basic and diluted weighted average ordinary shares outstanding |
||||||||
|
|
|
|
|||||
Basic and diluted net loss per ordinary share: |
$ | $ | ( |
) | ||||
|
|
|
|
• | in whole and not in part |
• | at a price of $ |
• | upon a minimum of |
• | if, and only if, the last reported sales price (the “closing price”) of the Class A ordinary shares equals or exceeds $ |
• | in whole and not in part; |
• | at $ provided |
• | if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted) for any 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and |
• | if the closing price of the Class A ordinary shares for any 20 trading days within a |
Gross proceeds |
$ | |||
Less: |
||||
Fair value of Public Warrants at issuance |
( |
) | ||
Offering costs allocated to Class A ordinary shares subject to possible redemption |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
|
|
|||
Class A ordinary share subject to possible redemption |
$ | |||
|
|
Fair Value Measured as of September 30, 2021 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets: |
||||||||||||||||
Investments held in Trust Account |
$ | $ |
— |
$ |
— |
$ | ||||||||||
Liabilities: |
||||||||||||||||
Derivative warrant liabilities - Public warrants |
— | — | ||||||||||||||
Derivative warrant liabilities - Private warrants |
— | — | ||||||||||||||
Total fair value |
$ | $ | — | $ | $ | |||||||||||
Fair Value Measured as of December 31, 2020 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets: |
||||||||||||||||
Investments held in Trust Account |
$ | $ |
— |
$ |
— |
$ | ||||||||||
Liabilities: |
||||||||||||||||
Derivative warrant liabilities - Public warrants |
— | — | ||||||||||||||
Derivative warrant liabilities - Private warrants |
— | — | ||||||||||||||
Total fair value |
$ | $ | — | $ | |
$ | ||||||||||
September 30, 2021 |
December 31, 2020 |
|||||||
Exercise price |
$ | |
$ | |
||||
Stock Price |
$ | $ | ||||||
Option term (in years) |
||||||||
Volatility |
% | % | ||||||
Risk-free interest rate |
% |
% |
Level 3 derivative warrant liabilities at January 1, 2021 |
$ | |||
Change in fair value of derivative warrant liabilities |
( |
) | ||
Level 3 derivative warrant liabilities at March 31, 2021 |
$ | |||
Change in fair value of derivative warrant liabilities |
( |
) | ||
Level 3 derivative warrant liabilities at June 30, 2021 |
$ | |||
Change in fair value of derivative warrant liabilities |
( |
) | ||
Level 3 derivative warrant liabilities at September 30, 2021 |
$ | |||
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
Item 4. |
Controls and Procedures (As Restated) |
Item 1. |
Legal Proceedings |
Item 1A. |
Risk Factors. |
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities |
Item 3. |
Defaults Upon Senior Securities |
Item 4. |
Mine Safety Disclosures |
Item 5. |
Other Information |
Item 6. |
Exhibits. |
Exhibit Number |
Description | |
31.1 | Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1 | Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
101.INS* | Inline XBRL Instance Document | |
101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |
101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
* | Filed herewith. |
TURMERIC ACQUISITION CORP. | ||
By: | /s/ Luke Evnin | |
Name: | Luke Evnin | |
Title: | Chief Executive Officer |